Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Market Closed - BME 11:35:50 2026-08-19 am EDT			5-day change	1st Jan Change
59.70 ^EUR	+2.93%		+3.29%	-5.98%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.56B		BBB
ELI LILLY AND COMPANY	1,141B		A
JOHNSON & JOHNSON	659B	-	BBB	-	-
ABBVIE INC.	470B		AA		-
ROCHE HOLDING AG	366B		AA
NOVARTIS AG	302B		AAA
ASTRAZENECA PLC	254B		A
AMGEN INC.	239B		A
NOVO NORDISK A/S	207B		A
GILEAD SCIENCES, INC.	183B		AA
PFIZER INC.	161B		A
BRISTOL-MYERS SQUIBB COMPANY	138B		A
VERTEX PHARMACEUTICALS INCORPORATED	140B		AA
SANOFI	110B		AA
GSK PLC	104B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	71.47B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	58.12B		AA
BAYER AG	56.13B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	51.57B		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	43.66B		-
Average	237.93B		AA
Weighted average by Cap.			AA